MCID: ALB009
MIFTS: 41

Albinism, Oculocutaneous, Type Ia

Categories: Genetic diseases, Rare diseases, Eye diseases, Skin diseases, Metabolic diseases

Aliases & Classifications for Albinism, Oculocutaneous, Type Ia

MalaCards integrated aliases for Albinism, Oculocutaneous, Type Ia:

Name: Albinism, Oculocutaneous, Type Ia 53 13
Oculocutaneous Albinism Type 1 72 23 49 55 28 69
Oca1a 53 49 55 71
Oca1 53 23 49 55
Atn 53 49 71
Oculocutaneous Albinism, Tyrosinase-Negative 53 51
Tyrosinase-Negative Oculocutaneous Albinism 55 28
Oculocutaneous Albinism Type 1a 49 55
Albinism I 53 71
Oculocutaneous Albinism, Tyrosinase-Negative; Atn 53
Oculocutaneous Albinism, Tyrosinase Negative 49
Oculocutaneous Albinism Tyrosinase Negative 71
Oculocutaneous Albinism, Type I; Oca1 53
Oculocutaneous Albinism, Type I 53
Albinism, Oculocutaneous, 1a 71
Albinism Oculocutaneous Ia 71
Albinism, Oculocutaneous 41
Albinism 1 49
Oca-1a 71
Oca-Ia 71

Characteristics:

Orphanet epidemiological data:

55
oculocutaneous albinism type 1
Inheritance: Autosomal recessive; Age of onset: Infancy,Neonatal;
oculocutaneous albinism type 1a
Inheritance: Autosomal recessive; Prevalence: 1-9/100000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: normal life expectancy;

OMIM:

53
Inheritance:
autosomal recessive

Miscellaneous:
congenital onset
complete absence of melanin synthesis
pigment does not develop with age
prevalence of 1 in 28,000 caucasians
prevalence of 1 in 28,000 african-americans
one of the 2 most common forms of albinism in the world, along with oca2
see also oca1b, or 'yellow albinism,' an allelic disorder with residual tyrosinase activity and some pigmentation


HPO:

31
albinism, oculocutaneous, type ia:
Onset and clinical course congenital onset
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Albinism, Oculocutaneous, Type Ia

OMIM : 53 Oculocutaneous albinism is a genetically heterogeneous congenital disorder characterized by decreased or absent pigmentation in the hair, skin, and eyes. The term 'albinism' includes specific ocular changes that are the results of reduced amounts of melanin in the developing eye; these abnormalities in the eye and optic system are specific and necessary for the diagnosis. Aside from decreased pigment in the iris and retina, optic changes include decreased visual acuity, misrouting of the optic nerves at the chiasm, and nystagmus (King et al., 2001). Although OCA caused by mutations in the TYR gene was classically known as 'tyrosinase-negative' OCA, Tripathi et al. (1992) noted that some patients with 'tyrosinase-positive' OCA may indeed have TYR mutations resulting in residual enzyme activity. These patients can be classified as having OCA1B. (203100)

MalaCards based summary : Albinism, Oculocutaneous, Type Ia, also known as oculocutaneous albinism type 1, is related to minimal pigment oculocutaneous albinism type 1 and acute kidney tubular necrosis, and has symptoms including photophobia, nystagmus and visual impairment. An important gene associated with Albinism, Oculocutaneous, Type Ia is TYR (Tyrosinase). The drug Nitisinone has been mentioned in the context of this disorder. Affiliated tissues include skin, eye and retina.

UniProtKB/Swiss-Prot : 71 Albinism, oculocutaneous, 1A: An autosomal recessive disorder in which the biosynthesis of melanin pigment is absent in skin, hair, and eyes. It is characterized by complete lack of tyrosinase activity due to production of an inactive enzyme. Patients present with a life-long absence of melanin pigment after birth, and manifest increased sensitivity to ultraviolet radiation with predisposition to skin cancer. Visual anomalies include decreased acuity, nystagmus, strabismus and photophobia.

NIH Rare Diseases : 49 Oculocutaneous albinism type 1 is a condition that affects the coloring of the skin, hair, and eyes. Signs and symptoms include very fair skin, white hair, an increased risk for skin damage with sun exposure, reduced vision (sharpness), light colored irises, nystagmus, and photophobia (eyes are sensitive to light). It is caused by changes in the TYR gene and is inherited in an autosomal recessive fashion. Last updated: 11/7/2011

Wikipedia : 72 Oculocutaneous Albinism Type I or –Type 1A (OCA1A) is an autosomal recessive skin disease associated... more...

GeneReviews: NBK1166

Related Diseases for Albinism, Oculocutaneous, Type Ia

Graphical network of the top 20 diseases related to Albinism, Oculocutaneous, Type Ia:



Diseases related to Albinism, Oculocutaneous, Type Ia

Symptoms & Phenotypes for Albinism, Oculocutaneous, Type Ia

Symptoms via clinical synopsis from OMIM:

53
Head And Neck Eyes:
photophobia
nystagmus
strabismus
foveal hypoplasia
decreased visual acuity
more
Skin Nails Hair Skin:
milky white skin
absent skin pigmentation
no ability to tan

Skin Nails Hair Hair:
white hair

Laboratory Abnormalities:
absent tyrosinase activity


Clinical features from OMIM:

203100

Human phenotypes related to Albinism, Oculocutaneous, Type Ia:

55 31 (show all 23)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 photophobia 55 31 hallmark (90%) Very frequent (99-80%) HP:0000613
2 nystagmus 55 31 hallmark (90%) Very frequent (99-80%) HP:0000639
3 visual impairment 55 31 frequent (33%) Frequent (79-30%) HP:0000505
4 abnormality of visual evoked potentials 55 31 frequent (33%) Frequent (79-30%) HP:0000649
5 hyperkeratosis 55 31 occasional (7.5%) Occasional (29-5%) HP:0000962
6 ocular albinism 55 31 hallmark (90%) Very frequent (99-80%) HP:0001107
7 squamous cell carcinoma of the skin 55 31 occasional (7.5%) Occasional (29-5%) HP:0006739
8 freckling 55 31 frequent (33%) Frequent (79-30%) HP:0001480
9 hypoplasia of the fovea 55 31 hallmark (90%) Very frequent (99-80%) HP:0007750
10 abnormality of the optic nerve 55 31 frequent (33%) Frequent (79-30%) HP:0000587
11 albinism 55 31 hallmark (90%) Very frequent (99-80%) HP:0001022
12 basal cell carcinoma 55 31 occasional (7.5%) Occasional (29-5%) HP:0002671
13 strabismus 31 HP:0000486
14 myopia 31 HP:0000545
15 reduced visual acuity 31 HP:0007663
16 hypopigmentation of hair 55 Very frequent (99-80%)
17 blue irides 31 HP:0000635
18 thickened skin 55 Occasional (29-5%)
19 white hair 31 HP:0011364
20 iris hypopigmentation 55 Very frequent (99-80%)
21 astigmatism 31 HP:0000483
22 hypopigmentation of the skin 55 Very frequent (99-80%)
23 absent skin pigmentation 31 HP:0200098

UMLS symptoms related to Albinism, Oculocutaneous, Type Ia:


photophobia

Drugs & Therapeutics for Albinism, Oculocutaneous, Type Ia

Drugs for Albinism, Oculocutaneous, Type Ia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitisinone Approved, Investigational Phase 1, Phase 2 104206-65-7 115355

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nitisinone for Type 1B Oculocutaneous Albinism Completed NCT01838655 Phase 1, Phase 2 Nitisinone
2 Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism Recruiting NCT00808106

Search NIH Clinical Center for Albinism, Oculocutaneous, Type Ia

Cochrane evidence based reviews: albinism, oculocutaneous

Genetic Tests for Albinism, Oculocutaneous, Type Ia

Genetic tests related to Albinism, Oculocutaneous, Type Ia:

# Genetic test Affiliating Genes
1 Oculocutaneous Albinism Type 1 28
2 Tyrosinase-Negative Oculocutaneous Albinism 28 TYR

Anatomical Context for Albinism, Oculocutaneous, Type Ia

MalaCards organs/tissues related to Albinism, Oculocutaneous, Type Ia:

38
Skin, Eye, Retina, Testes

Publications for Albinism, Oculocutaneous, Type Ia

Articles related to Albinism, Oculocutaneous, Type Ia:

(show all 22)
# Title Authors Year
1
Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1. ( 28112372 )
2017
2
Oculocutaneous Albinism Type 1: Link between Mutations, Tyrosinase Conformational Stability, and Enzymatic Activity. ( 27775880 )
2016
3
A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene. ( 24721949 )
2014
4
Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). ( 25216246 )
2014
5
[Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients]. ( 22097729 )
2011
6
Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients. ( 20861851 )
2011
7
A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China. ( 22088535 )
2011
8
Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1. ( 20447099 )
2010
9
Recurrent rhabdomyolysis in a patient with oculocutaneous albinism type 1 and platelet storage-pool deficiency. ( 19006216 )
2008
10
Polymorphisms in the genes for oculocutaneous albinism type 1 and type 4 in the German population. ( 17516931 )
2007
11
Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1. ( 17355913 )
2007
12
Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. ( 16417222 )
2006
13
Molecular basis of oculocutaneous albinism type 1 in Lebanese patients. ( 15937636 )
2005
14
Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: two novel frameshift mutations in the TYR Gene. ( 15635296 )
2004
15
A case of familial trichomegaly in association with oculocutaneous albinism type 1. ( 14752500 )
2004
16
Coinheritance of two rare genodermatoses (Papillon-LefA"vre syndrome and oculocutaneous albinism type 1) in two families: a genetic study. ( 15606524 )
2004
17
Oculocutaneous albinism type 1: the last 100 years. ( 12753405 )
2003
18
A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1). ( 11858948 )
2002
19
Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. ( 11641241 )
2001
20
The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. ( 11284711 )
2001
21
The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation. ( 11041207 )
2000
22
Oculocutaneous Albinism Type 1 ( 20301345 )
1993

Variations for Albinism, Oculocutaneous, Type Ia

UniProtKB/Swiss-Prot genetic disease variations for Albinism, Oculocutaneous, Type Ia:

71 (show top 50) (show all 101)
# Symbol AA change Variation ID SNP ID
1 TYR p.His19Gln VAR_007649 rs61753177
2 TYR p.Pro21Ser VAR_007650 rs61753178
3 TYR p.Asp42Gly VAR_007651 rs28940878
4 TYR p.Gly47Asp VAR_007652 rs61753180
5 TYR p.Cys55Tyr VAR_007654 rs28940879
6 TYR p.Arg77Gln VAR_007655 rs61753185
7 TYR p.Arg77Trp VAR_007656 rs61753184
8 TYR p.Trp80Arg VAR_007657 rs61753188
9 TYR p.Pro81Leu VAR_007658 rs28940876
10 TYR p.Cys89Arg VAR_007659 rs28940877
11 TYR p.Gly97Arg VAR_007660 rs61753252
12 TYR p.Phe176Ile VAR_007661 rs61753259
13 TYR p.Ala206Thr VAR_007663 rs28940880
14 TYR p.Leu216Met VAR_007664 rs61754363
15 TYR p.Arg217Gly VAR_007665 rs63159160
16 TYR p.Arg217Trp VAR_007666 rs63159160
17 TYR p.Arg217Gln VAR_007667 rs61754365
18 TYR p.Gly253Arg VAR_007668 rs61754369
19 TYR p.Val275Phe VAR_007669 rs104894314
20 TYR p.Cys289Arg VAR_007670
21 TYR p.Arg299His VAR_007671 rs61754375
22 TYR p.Arg299Ser VAR_007672 rs61754374
23 TYR p.Ser339Gly VAR_007676 rs62645906
24 TYR p.Ala355Pro VAR_007678 rs62645908
25 TYR p.Asn371Thr VAR_007679 rs61754387
26 TYR p.Thr373Lys VAR_007680 rs61754388
27 TYR p.Asn382Lys VAR_007682 rs104894315
28 TYR p.Asp383Asn VAR_007683 rs121908011
29 TYR p.Ser395Asn VAR_007685 rs752344007
30 TYR p.Arg403Ser VAR_007687 rs104894316
31 TYR p.Pro406Leu VAR_007689 rs104894313
32 TYR p.Gly419Arg VAR_007690 rs61754392
33 TYR p.Arg422Gln VAR_007691 rs61754393
34 TYR p.Gly446Ser VAR_007692 rs104894317
35 TYR p.Asp448Asn VAR_007693 rs104894318
36 TYR p.Leu288Ser VAR_007927
37 TYR p.Glu294Lys VAR_007928 rs757754120
38 TYR p.Glu328Gln VAR_007929 rs61754380
39 TYR p.Gly346Glu VAR_007930 rs773970123
40 TYR p.Ala355Glu VAR_007931
41 TYR p.Ser361Arg VAR_007932 rs61754383
42 TYR p.His367Tyr VAR_007933 rs776054795
43 TYR p.Met370Thr VAR_007934 rs61754385
44 TYR p.Asn371Tyr VAR_007935 rs61754386
45 TYR p.Val393Phe VAR_007936
46 TYR p.Pro431Leu VAR_007938 rs281865325
47 TYR p.Cys289Gly VAR_009237
48 TYR p.Trp400Leu VAR_009238 rs62645916
49 TYR p.Cys36Tyr VAR_021683 rs61753179
50 TYR p.Ser44Gly VAR_021684

ClinVar genetic disease variations for Albinism, Oculocutaneous, Type Ia:

6 (show top 50) (show all 60)
# Gene Variation Type Significance SNP ID Assembly Location
1 TYR NM_000372.4(TYR): c.272G> A (p.Cys91Tyr) single nucleotide variant Pathogenic rs137854890 GRCh37 Chromosome 11, 88911393: 88911393
2 TYR NM_000372.4(TYR): c.1037-1G> A single nucleotide variant Pathogenic rs61754382 GRCh37 Chromosome 11, 88960990: 88960990
3 TYR NM_000372.4(TYR): c.1037-7T> A single nucleotide variant Pathogenic/Likely pathogenic rs61754381 GRCh37 Chromosome 11, 88960984: 88960984
4 TYR NM_000372.4(TYR): c.1100A> G (p.His367Arg) single nucleotide variant Likely pathogenic rs61754384 GRCh37 Chromosome 11, 88961054: 88961054
5 TYR NM_000372.4(TYR): c.1199G> T (p.Trp400Leu) single nucleotide variant Likely pathogenic rs62645916 GRCh37 Chromosome 11, 89017955: 89017955
6 TYR NM_000372.4(TYR): c.1204C> T (p.Arg402Ter) single nucleotide variant Pathogenic rs62645917 GRCh37 Chromosome 11, 89017960: 89017960
7 TYR NM_000372.4(TYR): c.229C> T (p.Arg77Trp) single nucleotide variant Pathogenic rs61753184 GRCh37 Chromosome 11, 88911350: 88911350
8 TYR NM_000372.4(TYR): c.346C> T (p.Arg116Ter) single nucleotide variant Pathogenic rs61753256 GRCh37 Chromosome 11, 88911467: 88911467
9 TYR NM_000372.4(TYR): c.572delG (p.Gly191Aspfs) deletion Pathogenic rs61754361 GRCh37 Chromosome 11, 88911693: 88911693
10 TYR NM_000372.4(TYR): c.613C> A (p.Pro205Thr) single nucleotide variant Pathogenic rs61754362 GRCh37 Chromosome 11, 88911734: 88911734
11 TYR NM_000372.4(TYR): c.650G> A (p.Arg217Gln) single nucleotide variant Pathogenic rs61754365 GRCh37 Chromosome 11, 88911771: 88911771
12 TYR NM_000372.4(TYR): c.820-3C> G single nucleotide variant Pathogenic rs61754371 GRCh37 Chromosome 11, 88924367: 88924367
13 TYR NM_000372.4(TYR): c.832C> T (p.Arg278Ter) single nucleotide variant Pathogenic rs62645904 GRCh37 Chromosome 11, 88924382: 88924382
14 TYR NM_000372.4(TYR): c.895C> A (p.Arg299Ser) single nucleotide variant Pathogenic rs61754374 GRCh37 Chromosome 11, 88924445: 88924445
15 TYR NM_000372.4(TYR): c.551C> G (p.Ser184Ter) single nucleotide variant Likely pathogenic rs367543066 GRCh38 Chromosome 11, 89178504: 89178504
16 TYR NM_000372.4(TYR): c.739T> C (p.Cys247Arg) single nucleotide variant Likely pathogenic rs367543068 GRCh38 Chromosome 11, 89178692: 89178692
17 TYR NM_000372.4(TYR): c.902C> T (p.Pro301Leu) single nucleotide variant Likely pathogenic rs796051880 GRCh38 Chromosome 11, 89191284: 89191284
18 OCA2 NM_000275.2(OCA2): c.1327G> A (p.Val443Ile) single nucleotide variant Pathogenic/Likely pathogenic rs121918166 GRCh37 Chromosome 15, 28230247: 28230247
19 TYR NM_000372.4(TYR): c.929dupC (p.Arg311Lysfs) duplication Pathogenic rs281865527 GRCh37 Chromosome 11, 88924479: 88924479
20 TYR NM_000372.4(TYR): c.242C> T (p.Pro81Leu) single nucleotide variant Pathogenic/Likely pathogenic rs28940876 GRCh37 Chromosome 11, 88911363: 88911363
21 TYR NM_000372.4(TYR): c.823G> T (p.Val275Phe) single nucleotide variant Pathogenic rs104894314 GRCh37 Chromosome 11, 88924373: 88924373
22 TYR NM_000372.4(TYR): c.1118C> A (p.Thr373Lys) single nucleotide variant Pathogenic rs61754388 GRCh37 Chromosome 11, 88961072: 88961072
23 TYR NM_000372.4(TYR): c.1147G> A (p.Asp383Asn) single nucleotide variant Pathogenic rs121908011 GRCh37 Chromosome 11, 88961101: 88961101
24 TYR NM_000372.4(TYR): c.230G> A (p.Arg77Gln) single nucleotide variant Pathogenic rs61753185 GRCh37 Chromosome 11, 88911351: 88911351
25 TYR NM_000372.4(TYR): c.1217C> T (p.Pro406Leu) single nucleotide variant Pathogenic/Likely pathogenic rs104894313 GRCh37 Chromosome 11, 89017973: 89017973
26 TYR NM_000372.4(TYR): c.265T> C (p.Cys89Arg) single nucleotide variant Pathogenic rs28940877 GRCh37 Chromosome 11, 88911386: 88911386
27 TYR NM_000372.4(TYR): c.533G> A (p.Trp178Ter) single nucleotide variant Pathogenic rs61754360 GRCh37 Chromosome 11, 88911654: 88911654
28 TYR NM_000372.4(TYR): c.1146C> A (p.Asn382Lys) single nucleotide variant Pathogenic rs104894315 GRCh37 Chromosome 11, 88961100: 88961100
29 TYR NM_000372.4(TYR): c.732_733delTG (p.Cys244Terfs) deletion Pathogenic rs61754368 GRCh37 Chromosome 11, 88911853: 88911854
30 TYR NM_000372.4(TYR): c.286dupA (p.Met96fs) duplication Pathogenic rs61753190 GRCh37 Chromosome 11, 88911407: 88911407
31 TYR NM_000372.4(TYR): c.125A> G (p.Asp42Gly) single nucleotide variant Pathogenic rs28940878 GRCh37 Chromosome 11, 88911246: 88911246
32 TYR NM_000372.4(TYR): c.164G> A (p.Cys55Tyr) single nucleotide variant Pathogenic rs28940879 GRCh37 Chromosome 11, 88911285: 88911285
33 TYR NM_000372.4(TYR): c.616G> A (p.Ala206Thr) single nucleotide variant Pathogenic rs28940880 GRCh37 Chromosome 11, 88911737: 88911737
34 TYR NM_000372.4(TYR): c.1255G> A (p.Gly419Arg) single nucleotide variant Pathogenic rs61754392 GRCh37 Chromosome 11, 89018011: 89018011
35 TYR NM_000372.4(TYR): c.61C> T (p.Pro21Ser) single nucleotide variant Pathogenic rs61753178 GRCh37 Chromosome 11, 88911182: 88911182
36 TYR NM_000372.4(TYR): c.140G> A (p.Gly47Asp) single nucleotide variant Pathogenic rs61753180 GRCh37 Chromosome 11, 88911261: 88911261
37 TYR NM_000372.4(TYR): c.649C> T (p.Arg217Trp) single nucleotide variant Pathogenic/Likely pathogenic rs63159160 GRCh37 Chromosome 11, 88911770: 88911770
38 TYR NM_000372.4(TYR): c.896G> A (p.Arg299His) single nucleotide variant Pathogenic rs61754375 GRCh37 Chromosome 11, 88924446: 88924446
39 TYR NM_000372.4(TYR): c.1112A> C (p.Asn371Thr) single nucleotide variant Pathogenic rs61754387 GRCh37 Chromosome 11, 88961066: 88961066
40 TYR NM_000372.4(TYR): c.1164delT (p.His389Thrfs) deletion Pathogenic rs281865522 GRCh37 Chromosome 11, 88961118: 88961118
41 TYR NM_000372.4(TYR): c.1209G> T (p.Arg403Ser) single nucleotide variant Pathogenic/Likely pathogenic rs104894316 GRCh37 Chromosome 11, 89017965: 89017965
42 TYR NM_000372.4(TYR): c.1336G> A (p.Gly446Ser) single nucleotide variant Pathogenic rs104894317 GRCh37 Chromosome 11, 89018092: 89018092
43 TYR NM_000372.4(TYR): c.1342G> A (p.Asp448Asn) single nucleotide variant Pathogenic rs104894318 GRCh37 Chromosome 11, 89018098: 89018098
44 TYR NM_000372.4(TYR): c.1467dupT (p.Ala490Cysfs) duplication Pathogenic rs61754399 GRCh37 Chromosome 11, 89028411: 89028411
45 TYR NM_000372.4(TYR): c.1501dupC (p.Arg501Profs) duplication Pathogenic rs281865328 GRCh37 Chromosome 11, 89028445: 89028445
46 TYR NM_000372.4(TYR): c.707G> A (p.Trp236Ter) single nucleotide variant Pathogenic rs61754367 GRCh37 Chromosome 11, 88911828: 88911828
47 TYR NM_000372.4(TYR): c.646T> A (p.Leu216Met) single nucleotide variant Pathogenic rs61754363 GRCh37 Chromosome 11, 88911767: 88911767
48 TYR NM_000372.4(TYR): c.1A> G (p.Met1Val) single nucleotide variant Pathogenic rs28940881 GRCh37 Chromosome 11, 88911122: 88911122
49 TYR NM_000372.4(TYR): c.446A> G (p.Tyr149Cys) single nucleotide variant Likely pathogenic rs797046082 GRCh38 Chromosome 11, 89178399: 89178399
50 TYR NM_000372.4(TYR): c.658C> T (p.Gln220Ter) single nucleotide variant Pathogenic rs797046083 GRCh38 Chromosome 11, 89178611: 89178611

Expression for Albinism, Oculocutaneous, Type Ia

Search GEO for disease gene expression data for Albinism, Oculocutaneous, Type Ia.

Pathways for Albinism, Oculocutaneous, Type Ia

GO Terms for Albinism, Oculocutaneous, Type Ia

Sources for Albinism, Oculocutaneous, Type Ia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....